Literature DB >> 21046549

Reevaluation of gastroesophageal reflux disease as a risk factor for laryngeal cancer.

David O Francis1, Charles Maynard, Ernest A Weymuller, Gayle Reiber, Albert L Merati, Bevan Yueh.   

Abstract

OBJECTIVES/HYPOTHESIS: The relationship between gastroesophageal reflux disease (GERD) and laryngeal cancer has not been fully elucidated. This case-control study investigates whether GERD increases the odds of developing these malignancies. STUDY
DESIGN: Case-control study.
METHODS: Rates of GERD among cases of laryngeal cancer identified in the Veterans Health Administration outpatient care files (year 2000-2006) were compared with controls. Cases (N = 14,449) were frequency matched 1:1 with controls. Multivariate logistic regression was used to determine the association between GERD and cancer.
RESULTS: After adjusting for tobacco and/or alcohol use, there was no association between GERD and laryngeal cancer (adjusted odds ratio, 1.01; 95% confidence interval, 0.92-1.12, P =.780). Although an association was found when time from GERD diagnosis to malignancy was less than 3 months, it disappeared when this period was extended further.
CONCLUSIONS: In this population, there was no increased risk of laryngeal cancer among patients with GERD. However, in subsite analysis, a possible relationship between GERD and glottic cancer was observed. Reverse causality must be considered in future studies assessing the relationship between reflux and laryngeal cancer to limit misclassification bias.

Entities:  

Mesh:

Year:  2011        PMID: 21046549     DOI: 10.1002/lary.21165

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

1.  Laryngopharyngeal Reflux and Functional Laryngeal Disorder: Perspective and Common Practice of the General Gastroenterologist.

Authors:  Dhyanesh A Patel; Michael Blanco; Michael F Vaezi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-09

2.  Association of Gastroesophageal Reflux With Malignancy of the Upper Aerodigestive Tract in Elderly Patients.

Authors:  Charles A Riley; Eric L Wu; Mei-Chin Hsieh; Michael J Marino; Xiao-Cheng Wu; Edward D McCoul
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-02-01       Impact factor: 6.223

Review 3.  Gastroesophageal reflux disease and non-esophageal cancer.

Authors:  Fernando A M Herbella; Sebastião Pannocchia Neto; Ilka Lopes Santoro; Licia Caldas Figueiredo
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

4.  Gastric reflux is an independent risk factor for laryngopharyngeal carcinoma.

Authors:  Scott M Langevin; Dominique S Michaud; Carmen J Marsit; Heather H Nelson; Ariel E Birnbaum; Melissa Eliot; Brock C Christensen; Michael D McClean; Karl T Kelsey
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-05-23       Impact factor: 4.254

5.  Association of gastroesophageal reflux disease and laryngeal cancer.

Authors:  Mursalin M Anis; Mir-Muhammad Razavi; Xiao Xiao; Ahmed M S Soliman
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2018-04-11

Review 6.  Pepsin and Laryngeal and Hypopharyngeal Carcinomas.

Authors:  Cheng-Yi Yin; Sha-Sha Zhang; Jiang-Tao Zhong; Shui-Hong Zhou
Journal:  Clin Exp Otorhinolaryngol       Date:  2020-07-24       Impact factor: 3.372

7.  Gastroesophageal reflux disease: A risk factor for laryngeal squamous cell carcinoma and esophageal squamous cell carcinoma in the NIH-AARP Diet and Health Study cohort.

Authors:  Shao-Ming Wang; Neal D Freedman; Hormuzd A Katki; Charles Matthews; Barry I Graubard; Lisa L Kahle; Christian C Abnet
Journal:  Cancer       Date:  2021-02-22       Impact factor: 6.921

8.  Incidence and survival for oropharynx and non-oropharynx head and neck cancers among veterans living with HIV.

Authors:  Angela L Mazul; Christine Hartman; Jennifer Kramer; Donna L White; Kathryn Royse; Suchismita Raychaudhury; Vlad Sandulache; Sarah T Ahmed; Peter Richardson; Andrew G Sikora; Elizabeth Chiao
Journal:  Cancer Med       Date:  2020-10-23       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.